Morgan Stanley, a global investment bank, has placed Quantinuum on its shortlist of quantum computing companies to watch, initiating coverage with an equalweight rating and a $78 price target. The bank's analysts argue that Quantinuum's trapped-ion technology and growing roster of commercial and government partnerships give it a competitive edge, even though the industry is still years away from delivering large-scale, fault-tolerant quantum machines that can reliably correct errors.
Quantum computing remains an early-stage, high-stakes race. No one knows which hardware approach will ultimately win, when the technology will scale to practical use, or how quickly customers will pay for it. But Morgan Stanley believes the path is becoming clearer as researchers improve error correction—techniques to detect and fix computing mistakes—and as governments continue funding national quantum programs. Companies are also publishing more detailed roadmaps, which helps investors gauge progress.
Quantinuum's Edge: Trapped-Ion Tech and Partnerships
Quantinuum uses trapped-ion technology, which traps individual charged atoms (ions) in electromagnetic fields and uses lasers to perform calculations. This approach is known for high-fidelity operations and long coherence times, making it a strong contender for building reliable quantum computers. Morgan Stanley points to Quantinuum's progress on its trapped-ion systems and its expanding mix of partnerships with both commercial clients and government agencies as key differentiators.
The bank's model shows that Quantinuum's revenue won't meaningfully inflect until its planned platform launches: Sol in 2027 and Apollo in 2029. Earnings before interest, taxes, depreciation, and amortization (EBITDA)—a rough proxy for operating profit—is expected to turn positive in 2029. By 2030, Morgan Stanley projects Quantinuum could reach roughly $2.5 billion in revenue by capturing about a quarter of a $10 billion "quantum infrastructure" market. The $78 price target represents a modest premium over the current share price of $72.12.
What It Means for Investors
For everyday investors, this story is less about next quarter's earnings and more about a series of long-term checkpoints. When most of the growth is modeled years out—and EBITDA only turns positive in 2029—the stock trades less like a "beat or miss next quarter" story and more like a series of milestones. Small changes in confidence about whether Sol and Apollo arrive on time can shift expected cash flows and their present value by a lot.
That's why the biggest moves often cluster around roadmap proof points: technical milestones, customer deals that validate demand, and any updates that pull timelines forward or push them back. The key driver isn't incremental revenue today, but whether the 2027-2029 window still looks believable. Investors should watch for announcements about Sol's development progress, new partnerships, and any government funding awards.
This approach is similar to how analysts evaluate other emerging tech companies. For example, UBS recently highlighted how the data center boom could boost Innio's revenue tenfold by 2028, and RBC noted that Verisk's AI tools will take time to boost revenue. In both cases, the investment thesis hinges on future milestones rather than current earnings.
The Broader Quantum Landscape
Quantum computing is still in its infancy, but it has captured the imagination of investors and governments alike. The technology promises to solve problems that are intractable for classical computers, from drug discovery to cryptography to climate modeling. However, building a fault-tolerant quantum computer—one that can run complex algorithms without errors—remains a monumental engineering challenge.
Morgan Stanley's note acknowledges this reality. The bank is trying to balance hype with timelines, recognizing that the industry is still years away from commercial-scale machines. Yet it sees Quantinuum as well-positioned, thanks to its trapped-ion approach and partnerships. The bank's coverage initiation is a signal that institutional investors are starting to take quantum computing seriously as a long-term opportunity.
For context, other analysts have also been sizing up emerging tech opportunities. Oppenheimer recently estimated that Aramark's data center contracts could add $3-4 billion in revenue by 2028, highlighting how infrastructure plays are becoming a theme across tech and industrial sectors.
Key Takeaways for Everyday Investors
- Long time horizon: Quantinuum's revenue inflection isn't expected until 2027, and profitability until 2029. This is a long-term bet, not a short-term trade.
- Milestone-driven: The stock's value will hinge on technical and commercial milestones, not quarterly earnings. Watch for updates on Sol and Apollo launches, customer deals, and government contracts.
- High uncertainty: Quantum computing is still experimental. No one knows which technology will win or when it will scale. Diversification is key.
- Institutional interest: Morgan Stanley's coverage initiation suggests that Wall Street is beginning to pay attention to quantum computing as a potential growth area.
Morgan Stanley's $78 target leans on Sol in 2027 and Apollo in 2029. For investors, the key driver isn't incremental revenue today, but whether the 2027-2029 window still looks believable. As with any emerging technology, patience and a long-term perspective are essential.
